Prospective randomized comparison of single-dose versus 1-day cefazolin for prophylaxis in gynecologic surgery

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 4, 2005, Pages 384-389

  Su, Her Young ^a   Ding, Dah Ching ^b   Chen, Da Chung ^a   Lu, Mei Fen ^a   Liu, Jah Yao ^a   Chang, Feng Yee ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Antibiotic prophylaxis; Cefazolin; Gynecologic surgery; Surgical wound infection

Indexed keywords

CEFAZOLIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TROCAR; VAGINA; VAGINAL CUFF; VAGINITIS; WOUND INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFAZOLIN; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIAN CYSTS; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 16444366082     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00583.x     Document Type: Article

References (26)

1. McGowan JE. Cost and benefit of perioperative antimicrobial prophylaxis: methods for economic analysis. Rev Infect Dis 1991; 13: 879-89.
2. Dellinger EP, Gross PA, Barrett TL, Krause PJ, Martone WJ, McGowan JE Jr et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis 1994; 18: 422-7.
3. McDonald LC, Yu HT, Yin HC, Hsiung AC, Ho M. Use and abuse of surgical antibiotic prophylaxis in hospitals in Taiwan. J Formos Med Assoc 2001; 100: 5-13.
4. Chang SC, Chang HJ, Hsiao M. Antibiotic usage in public hospitals in Taiwan. J Microbiol Immunol Infect 1998; 31: 125-32.
5. Rozner MA. The American Society of Anesthesiologists physical status score and risk of perioperative infection. JAMA 1996; 275: 1544.
6. Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 152-7.
7. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20: 271-4.
8. Foster GE, Bourke JB, Bolwell J, Doran J, Balfour TW, Holliday A et al. Clinical and economic consequences of wound sepsis after appendectomy and their modification by metronidazole or povidone-iodine. Lancet 1981; 1: 769-71.
9. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326: 281-6.
10. Butts JD, Wolford ET. Timing of perioperative antibiotic administration. AORN J 1997; 65: 109-15.
11. Chalkiadakis GE, Gonnianakis C, Tsatsakis A, Tsakalof A, Michalodimitrakis M. Pre-incisional single-dose ceftriaxone for the prophylaxis of surgical wound infection. Am J Surg 1995; 170: 353-5.
12. Ronk LL. Surgical patients with multi-antibiotic-resistant bacteria. AORN J 1995; 61: 1023-7.
13. Mittendorf R, Aronson MP, Berry RE, Williams MA, Kupelnick B, Klickstein A et al. Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol 1993; 169: 1119-24.
14. Panella S, Abate D, Izzo S, Antonacci M. Short-term antibiotic prophylaxis in surgery. Clin Ter 1993; 143: 407-9.
15. Silver A, Eichorn A, Kral J, Pickett G, Barie P, Pryor V et al. Timeliness and use of antibiotic prophylaxis in selected inpatient surgical procedures. The Antibiotic Prophylaxis Study Group. Am J Surg 1996; 171: 548-52.
16. Matushek Kj Rosin E. Pharmacokinetics of cefazolin applied topically to the surgical wound. Arch Surg 1991; 126: 890-3.
17. Davidson AE, Clark C, Smith G. Postoperative wound infection: a computer analysis. Br J Surg 1971; 58: 333-7.
18. Matuschka PR. Improving the timing of antimicrobial prophylaxis. Am J Health Syst Pharm 1996; 53: 1846-9.
19. Armstrong CP, Taylor TV, Reeves DS. Pre-incisional intraparietal injection of cephamandole: a new approach to wound infection prophylaxis. Br J Surg 1982; 69: 459-60.
20. Fukatsu K, Saito H, Matsuda T, Ikeda S, Furukawa S, Muto T. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg 1997; 132: 1320-5.
21. Chen ML, Chang SC, Pan HJ, Hsueh PR, Yang LS, Ho SW et al. Longitudinal analysis of methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Formos Med Assoc 1999; 98: 426-32.
22. Fanning J, Sweetland DJ, Hilgers RD. A prospective randomized trial of ampicillin sulbactam vs cefoxitin prophylaxis for radical gynecologic surgery. Int J Gynecol Cancer 1996; 6: 298-301.
23. Marsden DE, Cavanagh D, Wisniewski BJ, Roberts WS, Lyman GH. Factors affecting the incidence of infectious morbidity after radical hysterectomy. Am J Obstet Gynecol 1985; 152: 817-21.
24. Schwandt A, Andrews SJ, Fanning J. Prospective analysis of a fever evaluation algorithm after major gynecologic surgery. Am J Obstet Gynecol 2001; 184: 1066-7.
25. Senior CC, Steigrad SJ. Are preoperative antibiotics helpful in abdominal hysterectomy? Am J Obstet Gynecol 1986; 154: 1004-8.
26. McNally CG, Krivak TC, Alagoz T. Conservative management of isolated posthysterectomy fever. J Reprod Med 2000; 45: 572-6.